核PTEN以酸酶独立的方式调节APC-CDH1瘤抑制综合体
Min Sup Song1, Arkaitz Carracedo, Leonardo Salmena
1Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Cell
|January 19, 2011
概括
核PTEN蛋白与APC/C相互作用,增强其瘤抑制活性. 这一发现解释了PTENPTEN的存在.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- PTEN (酸酶和张素同类基因) 是一个关键的瘤抑制基因,反对PI3K/AKT通路.
- PTEN的核定位对于其瘤抑制功能至关重要,但其特定的核作用尚未得到充分理解.
研究的目的:
- 阐明PTEN的核功能及其在抑制瘤中的作用.
- 为了研究核PTEN与亚纳相促进复合物/循环体 (APC/C) 复合物的相互作用.
主要方法:
- 研究了核PTEN和APC/C组件 (例如CDH1) 之间的相互作用.
- 评估了PTEN核排斥与酸酶失活对APC/C功能的影响.
- 分析了PTEN突变和零状态对APC/C标抑制剂 (PLK1,极光激酶) 的敏感性.
主要成果:
- 核PTEN直接与APC/C相互作用,并促进其与CDH1的关联,增强APC-CDH1复合物的活性.
- 核排除PTEN,而不是其酸酶活性,损害APC-CDH1功能,解释衰老对PTEN损失的反应.
- PTEN突变和无状态对PLK1和奥罗拉激酶抑制剂表现出不同的敏感性.
结论:
- 核PTEN作为APC-CDH1复合物的关键调节剂,有助于其瘤抑制作用.
- 这种机制解释了PTEN在细胞衰老中的作用以及催化不活性PTEN的瘤抑制活性.
- 这些发现为分层癌症患者和优化基于PTEN状态的向治疗提供了基础.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Allosteric Proteins-ATCase
4.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K
Anaphase Promoting Complex
2.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.5K


